Track Record
Z 9.76 (+10%) SCTY 5.25 (+11%) DD 2.65 (+4%) DVN -4.5 (-7%) TAN 4 (+12%) FEYE 4.2 (+17%) PEIX 2.2 (+23%) IBB 12 (+4%) QQQ 5.5 (+6%) SPY 9 (+5%) NTAP 2.51 (+6%) BIDU 12.54 (+6%) IYT 6.4 (+4%) SGG 2.33 (+5%) Options: MCP 0.23 (+57%) PSX -3.91 (-5%) BIDU 10 (+5%) SMH 1.82 (+4%) SYMC 1.13 (+5%) URBN 2.28 (+5%) Options: SWN 0.22 (+22%) SDRL -3.39 (-11%) CORN -3.02 (-11%) TMUS 1.23 (+4%) SWN -3.76 (-9%) SINA 0.25 (+1%) NUS 3 (+7%) CLF 1.31 (+9%) DNDN 0.22 (+16%) LUV -3.3 (-11%) CGA 0.6 (+20%) S 0.52 (+9%) X 2.45 (+6%) PHO 1.25 (+5%) FXE -2.95 (-2%) VXX 0.57 (+2%) YHOO 2.05 (+6%) DIS -6.2 (-7%) VXX 2.1 (+7%) SINA 2.4 (+4%) EWG 0.94 (+3%) BRK.B -5.1 (-4%) SPY 0.56 (+1%) Options: WFM 0.41 (+16%) EWC 1 (+3%) HIMX 0.57 (+9%) CVX 1.55 (+1%) UNG 0.07 (0%) Options: HPQ 0.3 (+34%) MMM 2.2 (+2%) FXC 0.6 (+1%) TBT -4.92 (-8%) IYT 4.3 (+2%) USO 0.62 (+1%) AXP -3.37 (-3%) CMG -77.75 (-13%) QCOM 3.55 (+4%) ORLY 3.9 (+3%) KO -1.74 (-4%) SNDK 10.65 (+10%) MA 3.42 (+5%) IBB 11.5 (+4%) CSCO 0.22 (+1%) RDY 3.36 (+8%) HDGE -0.57 (-5%) DD 2.4 (+4%) Options: CVX 0.18 (+12%) MU 0.8 (+2%) INTC -1.99 (-7%) VXX -5.5 (-15%) CLF 0.34 (+2%) FB -6.34 (-11%) TJX 0.78 (+1%) BA 4.9 (+4%) Options: IYT 0.4 (+26%) Options: DAL 1.05 (+100%) IYT -8.9 (-6%) CVX 2.2 (+2%) GE -0.48 (-2%) TWTR 2 (+6%) UNH 3.24 (+4%) TSN 2.2 (+5%) IWM 6.3 (+5%) WHR 8 (+5%) VXX -4.05 (-10%) FEYE -9.35 (-26%) CRM 2.64 (+5%) DANG 1.05 (+10%) WFM 0.51 (+1%) QCOM 4.35 (+5%) IBB 22 (+10%) NFLX 22 (+7%) SH 0.27 (+1%) IWM 5.35 (+5%) RIG 0.63 (+2%) MOS 0.77 (+2%) VXX 2.3 (+6%) NFLX 16.4 (+5%) GLD 1.75 (+1%) COG 1.07 (+2%) LNKD 17 (+11%) P 2.35 (+9%) VXX 2.2 (+5%) DDD 4.67 (+8%) FDX 2.46 (+2%) YHOO 3.6 (+9%) ADBE 2.62 (+4%) WDC -7.75 (-9%) PCLN 51 (+4%) FB 5.65 (+8%) AUY -1.34 (-13%) JJC 0.56 (+1%) SPY 1.6 (+1%) USO 0.37 (+1%) JO 3 (+8%) PCLN 42 (+3%) GILD 7.5 (+9%) PLUG 0.6 (+10%) PRGO -13.3 (-9%) VXX 2.4 (+5%) CORN 1.75 (+6%) BBBY 2.53 (+4%) TGT 0.00 (0%) HAL 0.4 (+1%) FCX 0.66 (+2%) MCP 0.32 (+7%) SINA 3 (+5%) PBR 0.56 (+5%) BA 5 (+4%) JCP -1.35 (-21%) PCLN 25 (+2%) BA 2 (+2%) ANF 2.3 (+7%) F 0.76 (+4%) AMZN 15 (+4%) VXX 3 (+7%) YHOO 2.17 (+5%) WYNN 3 (+2%) HAL 0.25 (+1%) AUY 0.6 (+7%) ROSG 0.95 (+30%) SINA -6.24 (-7%) TWTR 12 (+17%) ABIO 0.67 (+43%) CCXI 1 (+19%) TWGP 0.72 (+29%) TWTR 2.5 (+3%) NEWL 0.3 (+17%) WPRT -1.25 (-6%) ECTE 0.58 (+21%) FB 4.11 (+9%) CELG -15.66 (-10%)


Rant & Rave Blog

Dendreon's Bullish Case: Treat It Like An Option

Posted by Gareth Soloway Tuesday, August 12, 2014, 11:34AM ET

Read 750 times

Dendreon Corporation (NASDAQ:DNDN) is down 36% to $1.35 after the company said it may have to wipe out shareholder equity in the company to pay off debt. This sounds like a catastrophe but let's explore the nuances to better understand what is going on here. First, the company absolutely could file for bankruptcy. That is a worst case scenario for any investor buying at these levels. Now that we know the worst case, let's analyze the other side.

 

First, this debt that needs to be repaid and could cause bankruptcy is not due until January 2016. That means that they have almost 1.5 years to figure out a solution. Next, the company reported better than expected revenue and a smaller than expected loss in their latest quarter for their main drug Provenge. The bottom line is, this company is moving in the right direction on all metrics aside from the debt due in January 2016.

 

If this becomes an investment choice for you, my suggestion would be to treat it like an option. Options expire worthless if they hit the expiration and are out of the money. We know the expiration is January 2016. This 'option contract' has 16 months until the expiration and will only cost $1.35 as of today. Like an option, only put a little money into it. If the company can work out a deal, this stock could be valued north of $3.00 by January 2016, especially if Provenge sales continue to pick up. This is a very attractive play as well as another drug company could be interested in picking up Dendreon Corporation as a cheap investment in a drug that works and has a ton of potential. A buy out price could also be north of $3.00 per share.

 

Overall, Dendreon Corporation looks attractive at this level as long as investors understand the risk. Take the seven day, no obligation free trial to the Research Center and get swing trade alerts with entry and exit prices live as we trade. Just take a look at the calls we have given members here... then us and profit for life.

 

Gareth Soloway

Chief Market Strategist

www.InTheMoneyStocks.com

 

Comments


Leave a Comment


Back
Google+
Disclaimer: All comments made by InTheMoneyStocks, LLC and its subsidiaries, instructors, and representatives are for educational and informational purposes only and should not be construed as investment advice regarding the purchase or sale of securities, or any other financial instrument of any kind. Please consult with your financial adviser before making an investment decision regarding any securities mentioned herein. InTheMoneyStocks, LLC and its representatives assume no responsibility for your trading and investment results. All information on the website was obtained from sources believed to be reliable., but we do not warrant its completeness or accuracy, or warrant any results from the use of the information. InTheMoneyStocks, LLC, its employees, representatives and affiliated individuals may have a position or effect transactions in the securities herein and or otherwise employ trading strategies that may be consistent or inconsistent with the provided strategies. Trading of any type involves a very high degree of risk. Futures and Options trading are not suitable for all investors. Past results are not indicative of future results. InTheMoneyStocks, LLC, its subsidiaries and all affiliated individuals assume no responsibility for your trading and investment results.